Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001628280-23-008829

Director acquired 16,404 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
O'Meara Maeve Director 2023-03-17 Grant or award +16,404 59,104 D
Loading xslF345X04/wf-form4_167944617091630.xml…